Viewing Study NCT06384820

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:10 AM
Ignite Modification Date: 2026-05-07 @ 6:31 PM
Study NCT ID: NCT06384820
Status: WITHDRAWN
Last Update Posted: 2024-07-26
First Post: 2024-04-22
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Study of Cemiplimab Alone or in Combination With Fianlimab and/or Other Experimental Agents in Adult Participants With Peri-operative Stage III/IV Cutaneous Squamous Cell Carcinoma (CSCC)
Sponsor: Regeneron Pharmaceuticals
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cutaneous Squamous Cell Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Neoadjuvant View
None Adjuvant View
None Surgery View